Unknown

Dataset Information

0

Emergence of drug resistance in human immunodeficiency virus type 1 infected patients from pune, India, at the end of 12 months of first line antiretroviral therapy initiation.


ABSTRACT: Introduction. In India, 4,86,173 HIV infected patients are on first line antiretroviral therapy (ART) as of January 2012. HIV drug resistance (HIVDR) is drug and regimen-specific and should be balanced against the benefits of providing a given ART regimen. Material & Methods. The emergence of HIVDR mutations in a cohort of 100 consecutive HIV-1 infected individuals attending ART centre, on first line ART for 12 months, was studied. CD4(+) T-cell counts and plasma HIV-1 RNA level were determined. Result. Out of the 100 HIV-1 infected individuals, 81 showed HIVDR prevention (HIV-1 RNA level < 1000/mL), while the remaining 19 had HIV-1 viral RNA level > 1000/mL. HIVDR genotyping was carried out for individuals with evidence of virologic failure (HIV-1 RNA level > 1000/mL). The most frequent NRTI-associated mutation observed was M184V, while K103N/S was the commonest mutation at NNRTI resistance position. Conclusion. Our study has revealed the emergence of HIVDR in HIV-1 infected patients at the end of 12 months of first line ART initiation. For NRTIs, the prevalence of HIVDR mutations was 9% and 10% for NNRTIs. Our findings will contribute information in evidence-based decision making with reference to first and second line ART delivery and prevention of HIVDR emergence.

SUBMITTER: Patil RT 

PROVIDER: S-EPMC4003797 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Emergence of drug resistance in human immunodeficiency virus type 1 infected patients from pune, India, at the end of 12 months of first line antiretroviral therapy initiation.

Patil Rajesh T RT   Gupta Rajiv M RM   Sen Sourav S   Tripathy Srikanth P SP   Chaturbhuj Devidas N DN   Hingankar Nitin K NK   Paranjape Ramesh S RS  

ISRN AIDS 20140410


Introduction. In India, 4,86,173 HIV infected patients are on first line antiretroviral therapy (ART) as of January 2012. HIV drug resistance (HIVDR) is drug and regimen-specific and should be balanced against the benefits of providing a given ART regimen. Material & Methods. The emergence of HIVDR mutations in a cohort of 100 consecutive HIV-1 infected individuals attending ART centre, on first line ART for 12 months, was studied. CD4(+) T-cell counts and plasma HIV-1 RNA level were determined.  ...[more]

Similar Datasets

| S-EPMC9758821 | biostudies-literature
| S-EPMC6082173 | biostudies-literature
| S-EPMC5402603 | biostudies-literature
| S-EPMC3938931 | biostudies-literature
| S-EPMC4592848 | biostudies-literature
| S-EPMC3640753 | biostudies-literature
| S-EPMC6087680 | biostudies-literature
| S-EPMC9203343 | biostudies-literature
| S-EPMC8047862 | biostudies-literature
| S-EPMC6336906 | biostudies-other